WASHINGTON--(BUSINESS WIRE)--Abiomed, Inc. (NASDAQ: ABMD), today announced its planned schedule for the global live broadcasts of Impella 2.5 patient procedures at the Cardiovascular Research Foundation’s (CRF) annual Transcatheter Cardiovascular Therapeutics (TCT) scientific meeting, scheduled from Saturday, October 20 until Thursday, October 25, in Washington, D.C.
